Lantheus Holdings (LNTH) Non-Current Assets (2014 - 2026)
Lantheus Holdings (LNTH) reported Non-Current Assets of $1.4 billion for Q1 2026, up 122.39% year-over-year from $631.4 million in Q1 2025, and up 5.79% quarter-over-quarter from $1.3 billion in Q4 2025.
Lantheus Holdings (LNTH) Non-Current Assets (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Non-Current Assets data on file, last reported at $1.4 billion in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $1.4 billion, up 122.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 billion (up 81.87% YoY), and the FY2025 annual result was $1.3 billion, up 103.06% from the prior year.
- Non-Current Assets rose to $1.4 billion in Q1 2026 per LNTH's latest filing, from $1.3 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.4 billion in Q1 2026 and troughed at $565.3 million in Q4 2023.
- A 5-year average of $775.5 million and a median of $643.6 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2026: Non-Current Assets decreased 12.17% in 2023, then soared 122.39% in 2026.
- A 5-year view of Non-Current Assets shows it stood at $643.6 million in 2022, then decreased by 12.17% to $565.3 million in 2023, then advanced by 15.63% to $653.7 million in 2024, then jumped by 103.06% to $1.3 billion in 2025, then advanced by 5.79% to $1.4 billion in 2026.
- Business Quant data shows LNTH's Non-Current Assets at $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 68.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 914.26 Mn |
| Mar 31, 2025 | 631.44 Mn |
| Dec 31, 2024 | 653.71 Mn |
| Sep 30, 2024 | 753.92 Mn |
| Jun 30, 2024 | 708.69 Mn |
| Mar 31, 2024 | 682.53 Mn |
| Dec 31, 2023 | 565.33 Mn |
| Sep 30, 2023 | 573.18 Mn |
| Jun 30, 2023 | 585.50 Mn |
| Mar 31, 2023 | 576.01 Mn |
| Dec 31, 2022 | 643.64 Mn |
| Sep 30, 2022 | 594.04 Mn |
| Jun 30, 2022 | 609.40 Mn |
| Mar 31, 2022 | 608.42 Mn |
| Dec 31, 2021 | 627.99 Mn |
| Sep 30, 2021 | 646.30 Mn |
| Jun 30, 2021 | 671.59 Mn |